• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

湿性年龄相关性黄斑变性患者非正式照料者的经济负担和生活质量

Financial burden and quality of life of informal caregivers of patients with wet age-related macular degeneration.

作者信息

Weyer-Wendl Hannah, Walter Peter

机构信息

Department of Ophthalmology, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.

出版信息

Health Econ Rev. 2016 Dec;6(1):37. doi: 10.1186/s13561-016-0116-4. Epub 2016 Aug 26.

DOI:10.1186/s13561-016-0116-4
PMID:27562805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4999382/
Abstract

PURPOSE

The purpose of this research is to quantify the cost burden, care times and the impact on the quality of life (QoL) of informal caring relatives caring for patients with wet age-related macular degeneration (wet AMD). Moreover we investigated the impact of care times on the QoL.

METHODS

Through a specifically designed questionnaire, 150 caring relatives were interviewed retrospectively on all accrued financial costs, caring times incurred and the current QoL, assessed by a Visual Analogue Scale for happiness (VAS).

RESULTS

The caring time incurred was on average 6.4 ± 8.5 (mean +/- SD) hours per week. The QoL was on average rated at 6.7 ± 1.9 on a ten point scale. Financial strain was incurred by the direct non-medical costs of on average € 405 ± 1104 and the direct medical costs of on average € 134 ± 340 per year. Indirect costs were stated by two caregivers as amounting to € 2400 and € 6000 net income loss per year respectively. Caregivers of privately insured patients with wet AMD carried a financial cost burden which was up to six times higher than caregivers of patients who were on state insurance while showing the same visual acuity.

CONCLUSION

The evaluation shows that caregivers of privately insured patients with wet AMD have higher costs than caregivers of patients with state insurance coverage. This burden seems to be a factor to be considered independently since it does not appear to have any relation to patients AMD acuity.

摘要

目的

本研究旨在量化照顾湿性年龄相关性黄斑变性(湿性AMD)患者的非正式照顾亲属的成本负担、护理时间以及对生活质量(QoL)的影响。此外,我们还研究了护理时间对生活质量的影响。

方法

通过一份专门设计的问卷,对150名照顾亲属进行回顾性访谈,了解所有产生的财务成本、护理时间以及目前的生活质量,生活质量通过视觉模拟幸福量表(VAS)进行评估。

结果

每周的平均护理时间为6.4±8.5(均值±标准差)小时。生活质量在十分制量表上的平均评分为6.7±1.9。每年平均直接非医疗成本为405±1104欧元,直接医疗成本为134±340欧元,由此产生了财务压力。两名照顾者表示间接成本分别为每年净收入损失2400欧元和6000欧元。患有湿性AMD的私人保险患者的照顾者所承担的财务成本负担比视力相同但享受国家保险的患者的照顾者高出多达六倍。

结论

评估表明,患有湿性AMD的私人保险患者的照顾者比享受国家保险的患者的照顾者成本更高。这种负担似乎是一个需要独立考虑的因素,因为它似乎与患者的AMD视力没有任何关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/f53a52a736fe/13561_2016_116_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/be4172e59e7b/13561_2016_116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/582dd879c5fe/13561_2016_116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/e41af9b143c9/13561_2016_116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/796b83d93767/13561_2016_116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/f53a52a736fe/13561_2016_116_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/be4172e59e7b/13561_2016_116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/582dd879c5fe/13561_2016_116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/e41af9b143c9/13561_2016_116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/796b83d93767/13561_2016_116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba4/4999382/f53a52a736fe/13561_2016_116_Fig5_HTML.jpg

相似文献

1
Financial burden and quality of life of informal caregivers of patients with wet age-related macular degeneration.湿性年龄相关性黄斑变性患者非正式照料者的经济负担和生活质量
Health Econ Rev. 2016 Dec;6(1):37. doi: 10.1186/s13561-016-0116-4. Epub 2016 Aug 26.
2
The burden of neovascular age-related macular degeneration: a patient's perspective.新生血管性年龄相关性黄斑变性的负担:患者视角
Clin Ophthalmol. 2018 Dec 4;12:2483-2491. doi: 10.2147/OPTH.S185052. eCollection 2018.
3
[Evaluation of the German version of the caregiver reaction assessment questionnaire for informal caregivers of patients with neovascular age-related macular degeneration].[针对新生血管性年龄相关性黄斑变性患者的非专业照护者的照护者反应评估问卷德文版的评估]
Ophthalmologe. 2016 Mar;113(3):230-9. doi: 10.1007/s00347-015-0135-2.
4
Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand.泰国湿性年龄相关性黄斑变性患者的卫生资源利用及经济负担
Int J Ophthalmol. 2014 Feb 18;7(1):145-51. doi: 10.3980/j.issn.2222-3959.2014.01.27. eCollection 2014.
5
Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study.年龄相关性黄斑变性治疗中的疾病负担:一项时间与动作研究的结果
Am J Ophthalmol. 2015 Oct;160(4):725-31.e1. doi: 10.1016/j.ajo.2015.06.023. Epub 2015 Jul 2.
6
The social and economic burden on family caregivers for older adults in the Czech Republic.捷克共和国老年人家庭护理员的社会和经济负担。
BMC Geriatr. 2020 May 11;20(1):171. doi: 10.1186/s12877-020-01571-2.
7
Economic cost and quality of life of family caregivers of schizophrenic patients attending psychiatric hospitals in Ghana.加纳精神病院精神分裂症患者家庭照顾者的经济成本与生活质量
BMC Health Serv Res. 2017 Dec 4;17(Suppl 2):697. doi: 10.1186/s12913-017-2642-0.
8
Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada.在加拿大,与维替泊芬光动力疗法及标准治疗相比,培加他汀治疗中心凹下型湿性年龄相关性黄斑变性的成本效益。
Clin Ther. 2007 Sep;29(9):2096-106; discussion 2094-5. doi: 10.1016/j.clinthera.2007.09.001.
9
The direct and indirect financial costs of informal cancer care: A scoping review.非正式癌症护理的直接和间接经济成本:范围综述。
Health Soc Care Community. 2019 Sep;27(5):e622-e636. doi: 10.1111/hsc.12808. Epub 2019 Jul 10.
10
Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study.活动性渗出性年龄相关性黄斑变性患者的生活质量:EQUADE研究
Ophthalmologica. 2015;234(3):151-9. doi: 10.1159/000433448. Epub 2015 Aug 25.

引用本文的文献

1
Caregiver Burden Among Patients Receiving Anti-VEGF Intravitreal Injections for AMD and DR: A Cross-Sectional Study in Guangzhou.接受抗血管内皮生长因子玻璃体内注射治疗年龄相关性黄斑变性和糖尿病性视网膜病变患者的照顾者负担:广州的一项横断面研究
Clin Ophthalmol. 2025 Aug 30;19:3071-3078. doi: 10.2147/OPTH.S533237. eCollection 2025.
2
Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US.保加利亚、德国和美国晚期年龄相关性黄斑变性的经济负担
JAMA Ophthalmol. 2024 Dec 1;142(12):1123-1130. doi: 10.1001/jamaophthalmol.2024.4401.
3
Family Caregivers' Experiences of Living with Hemodialysis Patients: A Descriptive Phenomenology.

本文引用的文献

1
[Evaluation of the German version of the caregiver reaction assessment questionnaire for informal caregivers of patients with neovascular age-related macular degeneration].[针对新生血管性年龄相关性黄斑变性患者的非专业照护者的照护者反应评估问卷德文版的评估]
Ophthalmologe. 2016 Mar;113(3):230-9. doi: 10.1007/s00347-015-0135-2.
2
Prevalence and causes of registered blindness in the largest federal state of Germany.德国最大联邦州的登记致盲率及致盲原因。
Br J Ophthalmol. 2011 Aug;95(8):1061-7. doi: 10.1136/bjo.2010.194712. Epub 2011 Mar 3.
3
The impact of vision impairment on vision-specific quality of life in Germany.
家庭照顾者与血液透析患者共同生活的经历:一项描述性现象学研究
Iran J Nurs Midwifery Res. 2024 Sep 4;29(5):535-541. doi: 10.4103/ijnmr.ijnmr_276_22. eCollection 2024 Sep-Oct.
4
The economics of vision impairment and its leading causes: A systematic review.视力损害及其主要病因的经济学:一项系统综述。
EClinicalMedicine. 2022 Mar 22;46:101354. doi: 10.1016/j.eclinm.2022.101354. eCollection 2022 Apr.
5
Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study.息肉样脉络膜血管病变患者对治疗效果的感知:一项初步研究。
Int J Environ Res Public Health. 2020 Sep 2;17(17):6378. doi: 10.3390/ijerph17176378.
6
The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting.在日本单中心真实世界环境中,不同抗血管内皮生长因子治疗方案对减轻湿性年龄相关性黄斑变性患者及其照护者负担的影响。
PLoS One. 2017 Dec 8;12(12):e0189035. doi: 10.1371/journal.pone.0189035. eCollection 2017.
视力损伤对德国视功能特定生活质量的影响。
Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3613-9. doi: 10.1167/iovs.10-7127.
4
Vision-specific quality-of-life research: a need to improve the quality.特定视力相关生活质量研究:提高质量的必要性。
Am J Ophthalmol. 2011 Feb;151(2):195-7.e2. doi: 10.1016/j.ajo.2010.09.020.
5
[Methods for estimating personal costs of disease using retinal diseases as an example].[以视网膜疾病为例估算疾病个人成本的方法]
Ophthalmologe. 2010 Mar;107(3):216-20, 222. doi: 10.1007/s00347-009-2036-8.
6
Family caregiver social problem-solving abilities and adjustment to caring for a relative with vision loss.家庭照顾者的社会问题解决能力以及对照顾视力受损亲属的适应情况。
Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1585-92. doi: 10.1167/iovs.08-2744. Epub 2008 Dec 5.
7
[Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications].[德国的新生血管性年龄相关性黄斑变性。对生活质量的影响及经济负担]
Ophthalmologe. 2009 Mar;106(3):242-51. doi: 10.1007/s00347-008-1797-9.
8
Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy.法国、德国和意大利湿性年龄相关性黄斑变性患者的视力与医疗及非医疗费用之间的关联
Drugs Aging. 2008;25(3):255-68. doi: 10.2165/00002512-200825030-00007.
9
Impact of spouse vision impairment on partner health and well-being: a longitudinal analysis of couples.配偶视力障碍对伴侣健康和幸福感的影响:一项对夫妻的纵向分析
J Gerontol B Psychol Sci Soc Sci. 2007 Sep;62(5):S315-22. doi: 10.1093/geronb/62.5.s315.
10
Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss.医疗保险受益人中视力丧失与较高医疗费用之间的关联:进行性视力丧失者的费用更高。
Ophthalmology. 2007 Feb;114(2):238-45. doi: 10.1016/j.ophtha.2006.07.054.